Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Total Current Liabilities (2020 - 2025)

Quipt Home Medical (QIPT) has disclosed Total Current Liabilities for 6 consecutive years, with $75.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 31.81% year-over-year to $75.2 million, compared with a TTM value of $75.2 million through Dec 2025, up 31.81%, and an annual FY2025 reading of $74.7 million, up 22.77% over the prior year.
  • Total Current Liabilities was $75.2 million for Q4 2025 at Quipt Home Medical, up from $74.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $75.2 million in Q4 2025 and bottomed at $32.7 million in Q3 2021.
  • Average Total Current Liabilities over 5 years is $58.2 million, with a median of $60.6 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 45.12% in 2023, then rose 0.46% in 2024.
  • Year by year, Total Current Liabilities stood at $32.7 million in 2021, then grew by 27.5% to $41.7 million in 2022, then skyrocketed by 45.12% to $60.6 million in 2023, then fell by 5.76% to $57.1 million in 2024, then surged by 31.81% to $75.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for QIPT at $75.2 million in Q4 2025, $74.7 million in Q3 2025, and $59.8 million in Q2 2025.